Skeletal Muscle Density Is Independently Prognostic of Outcomes in Newly Diagnosed Mantle Cell Lymphoma Patients: Post Hoc Analysis of LYM 3002

Authors :: Chu, Michael P.
Belch, Andrew
Pei, Lixia
Yang, Xue (Loya)
Robak, Tadeusz
Rooney, Brendan
Cakana, Andrew
van de Velde, Helgi
Sawyer, Michael B
Source :: Blood; December 2015, Vol. 126 Issue: 23 p1477-1477, 1p
Publication Year :: 2015
Abstract: Belch: Janssen-Cilag: Consultancy. Pei:Janssen Research and Development: Employment; Johnson & Johnson: Other: Stock Ownership. Yang:Janssen Research and Development: Employment. Robak:Janssen: Consultancy, Research Funding; MorphoSys AG: Consultancy, Honoraria, Research Funding. Rooney:Janssen Research and Development: Employment; Johnson & Johnson: Other: Stock Ownership. Cakana:Janssen Research and Development: Employment. van de Velde:Millennium Pharmaceuticals, Inc.: Employment; Johnson & Johnson: Equity Ownership.

Full Text Access

Tools